| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.3M | — |
| R&D Expense | $63.6M | +11.2% |
| SG&A Expense | $30.5M | +12.0% |
| Operating Income | -$91.9M | -8.7% |
| Pre-tax Income | -$83.4M | -2.8% |
| Income Tax | $141K | +422.2% |
| Net Income | -$83.6M | -3.0% |
| EPS (Basic) | -$9.37 | +82.3% |
| EPS (Diluted) | -$9.37 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.6M | -66.5% |
| Short-term Investments | $70.5M | — |
| Accounts Receivable | $1.7M | — |
| Current Assets | $131.5M | -23.9% |
| Total Assets | $226.2M | +2.1% |
| Current Liabilities | $15.0M | -23.2% |
| Total Liabilities | $65.8M | +27.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.1M | +10.7% |
| Capital Expenditures | $17.9M | +128.5% |
| Investing Cash Flow | -$123.3M | -1204.9% |
| Financing Cash Flow | $69.4M | -63.1% |
| Free Cash Flow | -$78.0M | -3.8% |
| +82.3% |
| Stockholders' Equity |
| $160.4M |
| -5.6% |